Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-03-29
2005-03-29
Devi, S. (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007310, C435S007720, C435S007920, C435S975000
Reexamination Certificate
active
06872540
ABSTRACT:
A method and apparatus for the differentiation of Crohn's disease from other gastrointestinal illnesses, such as ulcerative colitis and irritable bowel syndrome, using the presence of fecal anti-Saccharomyces cerevisiaeantibodies (ASCA) as a marker for Crohn's disease are provided. The apparatus includes an enzyme-linked immunoassay or other immunoassay that utilizes antibodies specific to human immunoglobins for the measurement of total endogenous ASCA in a human fecal sample. The method and apparatus may be used by healthcare providers to distinguish Crohn's disease from other gastrointestinal illnesses, such as ulcerative colitis and irritable bowel syndrome.
REFERENCES:
patent: 5359038 (1994-10-01), Padron
patent: 5932429 (1999-08-01), Targan et al.
patent: 5968741 (1999-10-01), Plevy et al.
patent: 6218129 (2001-04-01), Walsh et al.
patent: WO 9739356 (1997-10-01), None
patent: WO 9846997 (1998-10-01), None
patent: WO 9960403 (1999-11-01), None
patent: WO 0111334 (2001-02-01), None
HCAPLUS Abstrcat of US 6667160 (one page).*
R. Barnes, S. Allan, C. Taylor-Robinson, R. Finn, P. Johnson, “Serum Antibodies Reactive withSaccharomyces cerevisiaein Inflammatory Bowel Disease: Is IgA Antibody a Marker for Crohn's Disease?”Int Arch Allergy Appl Immunol(1990) 92, 9-15.
C. Faille, D. Mackenzie, J. Michalski, and D. Poulain, “Evaluation of an Enzyme Immunoassay Using Neoglycolipids Constructed fromCandida albicansOligomannosides to Define the Specificity of Anti-Mannan Antibodies”Eur. J. Clin. Microbiol. Infect. Dis., (1992) May, 438-446.
M. Giaffer and C. Holdsworth, “Antibodies toSaccharomyces cerevisiaein patients with Crohn's disease and their possible pathogenic importance”Gut(1992) 33, 1071-1075.
S. Hanaues, “Inflammatory Bowel Disease”The New England Journal of Medicine(1996) 334, 841-848.
Hauther and G. D'Haens, “Medical Management of Ulcerative Colitis” in Targan and Shanahan Inflammatory Bowel Disease: From Bench to Bedside,Williams and Wilkens(1994) 545-561.
C. Jongeneel, L. Briant, I. Udalova, A. Sevin, S. Nedospasov, and A. Thomsen, “Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes”Proc. Natl. Acad. Sci. USA(1991) 88, 9717-9721.
E. Lindberg, K. Magnusson, C. Tysk, and G. Jarnerot, “Antibody (IgG, IgA, and IgM) to baker's yeastSaccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease”Gut(1991) 909-913.
J. Main, H. McKenzie, G. Yeaman, M. Kerr, D. Robson, C. Pennington, and D. Parratt, “Antibody toSaccharomyces cerevisiae(bakers' yeast) in Crohn's disease”BMJ(1988) 297 1105-1106.
H. McKenzie, J. Main, C. Pennington, and D. Parratt, “Antibody to selected strains ofSaccharomyces cerevisiae(baker's and brewer's yeast) andCandida albicansin Crohn's disease”Gut(1990) 31, 537-538.
H. McKenzie, D. Parratt, J. Main, and C. Pennington, “Antigenic heterogeneity of strains ofSaccharomyces cerevisiaeandCandida albicansrecognized by serum antibodies from patients with Crohn's disease”FEMS Microbiology Immunology(1992) 89, 219-224.
H. Yang, J. Rotter, H. Toyoda, C. Landers, D. Tyan, C. McElree, and S. Targan, “Ulcerative Colitis: A Genetically Heterogeneous Disorder Defined by Genetic (HLA Class II) and Subclinical (Antineutrophil Cytoplasmic Antibodies) Markers”The American Society for Clinical Investigation, Inc. (1993) 92, 1080-1084.
C. Young, A. Sonnenberg, and E. Burns, “Lymphocyte Proliferation Response to Baker's Yeast in Crohn's Disease”Digestion(1994) 55, 40-43.
M. Giaffer, A. Clark, C. Holdsworth, “Antibodies againstSaccharomyces Cervisiae(Baker's & Brewer's yeast) in Crohn's Disease”Gastorenterology(1991) 100, No. 5, Part 2.
G. Barclay, H. McKenzie, J. Pennington, D. Parratt, and C. Pennington, “The Effect of Dietary Yeast on the Activity of Stable Chronic Crohn's Disease”Scand J Gastroenterol(1992) 27, 196-200.
M. Broker, H. Harthus, and R. Barnes, “A murine monoclonal antibody directed against a yeast cell wall glycoprotein antigen of the yeast genusSaccharomyces” FEMS Microbiology Letters (1994) 118, 297-304.
C. Darroch, S. Christmas, and R. Barnes, “In vitrohuman lymphocyte proliferative responses to a glycoprotein of the yeastSaccharomyces cerevisiae” Immunology Letters(1994) 81, 247-252.
B. Heelan, S. Allan, and R. Barnes, “Identification of a 200-kDa glycoprotein antigen ofSaccharomyces cerevisiae” Immunology Letters(1991) 28, 181-186.
C. Galperin and M. Gershwin, Immunopathogenesis of Gastrointestinal and Hepatobiliary Diseases,JAMA, (1997) 278, 1946-1955.
R. Barnes, S. Allan, C. Robinson, R. Finn, and P. Johnson, “Serum Antibodies Reactive withSaccharomyces cerevisiaein Inflammatory Bowel Disease: Is IgA Antibody a Merker for Crohn's Disease?”Int. Arch. Allergy Appl. Immuno(1990) 92, 9-15.
J. Colomber, B. Sendid, J. Quinton, P. Jacquinot, O. Goulet, A Cortot, D. Poulain, “Anti-Saccharomyces cerevisiaeAntibodies: A New Subclinical Marker for Crohn's Disease”Gastroenterology(1996) 110, No. 4.
N. Oshitani, et al., IgG subclasses of antiSaccharomyces cerevisiaeantibody in inflammatory bowel disease; Blackwell Science Ltd., European Journal of Clinical Investigation, vol. 31, pp. 221-225, 2001.
Boone James Hunter
Lyerly David Maxwell
Wilkins Tracy Dale
Devi S.
Shook Hardy & Bacon L.L.P.
Techlab, Inc.
LandOfFree
Method and apparatus for distinguishing Crohn's disease from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for distinguishing Crohn's disease from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for distinguishing Crohn's disease from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3392511